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SUMMARY 
Mechanotransduction pathways are activated in response to biophysical 
stimuli and play important roles in development and the homeostasis of 
organs and tissues. During zebrafish cardiovascular development, the 
blood flow-sensitive transcription factor Klf2a promotes VEGF-dependent 
angiogenesis. However, the role of Klf2a in a mechanotransduction 
pathway and the means by which such a pathway is regulated to prevent 
continuous angiogenesis remain unknown. Here we report that the 
upregulation of klf2 mRNA causes enhanced egfl7 expression and 
angiogenesis signaling, which underlies morphogenetic cardiovascular 
defects associated with the loss of cerebral cavernous malformations 
(CCM) proteins in the zebrafish embryo. Using CCM protein-depleted 
human umbilical vein endothelial cells, we show that the misexpression of 
KLF2 mRNA requires the extracellular matrix-binding receptor ß1 integrin 
and occurs in the absence of blood flow. Downregulation of ß1 integrin in 
zebrafish embryos rescues ccm mutant cardiovascular malformations. Our 
work reveals a novel ß1 integrin-Klf2-Egfl7 signaling pathway that is under 
tight regulation by CCM proteins and their associated ß1 integrin-
regulatory protein ICAP1. This regulation prevents angiogenic overgrowth 
and ensures the quiescence and correct differentiation of endothelial cells.  
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INTRODUCTION 
During vertebrate embryogenesis, the basic morphology of the cardiovascular 
system is established prior to the onset of blood flow and is continuously 
modified in a process referred to as angiogenesis (Herbert and Stainier, 2011; 
Geudens and Gerhardt, 2011). During angiogenesis, endothelial cells (EC)s 
respond to biomechanical forces such as hemodynamics or extracellular matrix 
stiffness (Mammoto et al., 2012; Freund et al., 2012). These biophysical forces 
can modulate EC quiescence, the stabilization of cellular junctions, blood vessel 
lumen formation, and the formation of endocardial cushions within the heart. An 
important mediator of mechanosensitive responses to blood flow within ECs is 
the zinc-finger transcriptional regulator Krüppel-like factor 2 (KLF2). Within 
developing zebrafish aortic arch blood vessels, Klf2a activates a signaling 
cascade involving the endothelial-specific microRNA miR-126a that promotes 
VEGF-induced angiogenesis (Nicoli et al., 2010). Another factor that has been 
implicated in blood vessel morphogenesis and lumen formation is EGF-like-
domain, multiple 7 (egfl7) (Parker et al., 2004), a secreted protein that is 
associated with the blood vessel extracellular matrix (Soncin et al., 2003; Fitch et 
al., 2004). That the egfl7 locus also encodes mir-126 has complicated functional 
analyses of different mouse models used to determine the roles of egfl7 and of 
miR-126 in blood vessel development (Schmidt et al., 2007; Kuhnert et al., 2008; 
Wang et al., 2008). Under physiological conditions, egfl7 is expressed in the 
vasculature (Parker et al., 2004) and its promoter contains a putative Klf2 binding 
site (Harris et al., 2010). Besides a proangiogenic activity, KLF2 also elicits a 
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broad range of transcriptional changes with a vasoprotective function within ECs 
of mature blood vessels and promotes the attachment and stability of associated 
pericytes or vascular smooth muscle cells (Lee et al., 2006; Dekker et al., 2006; 
Parmar et al., 2006). Within the zebrafish heart, Klf2a is activated by reversible 
blood flow patterns and is needed for the morphogenesis of functional cardiac 
valves (Vermot et al., 2009). Despite its pivotal role for vessel remodeling and 
integrity, neither the precise KLF2 mechanotransduction-related signaling 
pathway nor the mechanisms involved in the shift from proangiogenic to 
vasoprotective KLF2 activity are known.  
Correct vascular development and integrity involve a complex of proteins called 
Cerebral Cavernous Malformation (CCM) proteins, which have inhibitory roles 
during angiogenesis and attenuate Rho kinase signaling which limits vascular 
permeability (Faurobert and Albiges-Rizo, 2010; Fischer et al., 2013). A loss of 
any of the three intracellular proteins KRIT1/CCM1, CCM2/OSM, or 
PDCD10/CCM3 results in cerebral cavernous malformations (Fischer et al., 
2013), a group of vascular diseases characterized by cerebral hemorrhages that 
occur predominantly within low-flow venous capillary beds and that lack typical 
vessel wall components such as pericytes and vascular smooth muscle cells 
(Zawistowski et al., 2005; Voss et al., 2007; Zhang et al., 2007). Proteins of the 
CCM complex assemble around the transmembrane protein Heart of glass 
(HEG) (Kleaveland et al., 2009). The entire CCM protein complex is involved in 
endothelial junctional stabilization and directly interacts with the vascular 
endothelial-Cadherin complex (Glading et al., 2007). In addition, the CCM 
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complex represses the activity of β1 integrin by stabilizing KRIT1-binding Integrin 
cytoplasmic domain associated protein 1 (ICAP1) (Faurobert et al., 2013), a 
specific inhibitor of β1 integrin (Millon-Fremillon et al., 2008) that associates with 
KRIT1 (Zhang et al., 2001; Zawistowski et al., 2002). β1 integrins are important 
players in mediating inside-out and outside-in signaling between the intracellular 
milieu and the extracellular matrix (Hynes, 2002; Ross et al., 2013), and play a 
role in angiogenesis and vascular development (Avraamides et al., 2008;   
Carlson et al., 2008; Lei et al., 2008; Tanjore et al., 2008). A paralog of CCM2, 
CCM2L, has recently been implicated as a promoter of cardiovascular growth by 
blocking CCM2-mediated vascular integrity (Zheng et al., 2012). Upon loss of 
PDCD10/CCM3, a separate mechanism involving germinal center kinase III 
(Chan et al., 2011) or sterile 20-like kinases (Voss et al., 2007; Zheng et al., 
2010) has been implicated in defective vascular or Drosophila tracheal tube 
development (Song et al., 2013). Understanding the precise mechanism by 
which CCM proteins prevent uncontrolled angiogenesis and vessel leakage may 
provide insights into the mechanisms by which angiogenesis is fine-tuned during 
vascular maturation and in response to blood flow. 
Here, we show that the loss of CCM proteins results in a β1 integrin-dependent 
overexpression of klf2, which in turn causes an upregulation of egfl7 and 
promotes angiogenesis. Our findings imply that CCM proteins safeguard 
endothelial quiescence and restrict proangiogenic signaling in the absence of 
blood flow-induced biophysical stimuli.  
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RESULTS 
Overexpression of KLF2 mRNA is a conserved feature of CCM protein-
depleted endothelial cells in zebrafish, mouse and HUVECs  
A loss of CCM proteins causes a number of cardiovascular malformations in 
zebrafish and mouse including cardiac ballooning, heart looping defects, a failure 
of endocardial cushions to form, and defective blood vessel formation (Mably et 
al., 2003; Mably et al., 2006; Hogan et al., 2008; Boulday et al., 2009; Kleaveland 
et al., 2009; Zheng et al., 2010; Yoruk et al., 2012). To identify the transcriptional 
changes responsible for such defects, we performed a comparative 
transcriptome analysis using cardiac tissue, which is rich in endocardial cells, 
isolated from ccm2m201 mutant and wild-type (WT) zebrafish embryos. We found 
that the two homologous blood-flow-responsive genes klf2a and klf2b were 
upregulated in ccm2m201 mutant hearts; we confirmed the upregulation of klf2a 
and klf2b in whole embryos at 48 hours post fertilization (hpf) by RT-qPCR (Fig. 
1A). To assess whether the upregulation of klf2 expression upon loss of CCM 
proteins is conserved in higher vertebrates, we next analyzed the conditional 
endothelial deletion of murine CCM2 (iCCM2). The loss of CCM2 within 
endothelial cells at post-natal day 1 (P1) has been shown to cause cerebral-
cavernous-malformations-like vascular defects with a complete penetrance in the 
cerebellum and in the retina (Boulday et al., 2011). Consistently, we found that 
Klf2 mRNA levels were significantly elevated in the cerebellum of such iCCM2 
animals at P15 (Fig. 1B). Strikingly, in CCM2 siRNA-silenced human umbilical 
vein endothelial cells (HUVECs), KLF2 mRNA levels were also increased (Fig. 
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1C). Hence, klf2 mRNA overexpression is a conserved feature of CCM protein-
depleted ECs. 
To further elucidate whether klf2 overexpression is restricted to particular regions 
of the zebrafish embryonic vascular network, we next performed whole-mount in 
situ hybridizations. This analysis revealed that klf2a and klf2b were strongly 
overexpressed throughout the entire endocardium of zebrafish krit1ty219c and 
ccm2m201 mutants (Fig. 1D-F; supplementary Fig. S1) and within arteries and 
veins of ccm2m201 mutants (Fig. 1G,H). Taken together, these findings show that 
a loss of CCM proteins causes an upregulation of klf2 mRNA within different 
regions of the vascular network.  
Elevated levels of klf2 are necessary and sufficient to induce 
cardiovascular malformation phenotypes associated with the loss of CCM 
proteins in zebrafish 
Klf2 proteins are blood-flow responsive endothelial transcription factors with 
essential roles in vasculogenesis, angiogenesis, cardiac valve morphogenesis, 
regulation of vascular tone, and control of vasoprotective gene expression 
(Dekker et al., 2006; Lee et al., 2006; Parmar et al., 2006; Vermot et al., 2009; 
Nicoli et al., 2010). Based on the different cardiovascular functions of Klf2, we 
assessed whether high expression levels of klf2a and klf2b may be causative for 
the ccm2m201 mutant cardiovascular phenotype. The ccm2m201 cardiac phenotype 
is characterized by cardiac ballooning, endocardial overproliferation, and by a 
lack of cardiac cushions that normally form by 48hpf, as evidenced by the failure 
of endocardial cells to acquire a cuboidal shape and to express activated 
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leukocyte cell adhesion molecule (Alcam) (Fig. 2A-B’,J) (Jin et al., 2005). Within 
the ccm2m201 mutant vasculature, the lateral dorsal aortae (LDA) exhibit 
significant increases in endothelial cell numbers at 48 hpf, providing evidence for 
increased angiogenesis signaling (Fig. 2D,E,J). Similarly, within the trunk region 
region of ccm2m201 mutants, the subintestinal vein (SIV) exhibits a higher density 
of vessel branch points, which is another established marker for increased 
angiogenesis (Yu et al., 2010; Avraham-Davidi et al., 2012; Ghajar et al., 2013) 
(Fig. 2G,H,K). 
Strikingly, the partial reduction of both Klf2 proteins by coinjection of low doses of 
two antisense oligonucleotide morpholinos (MOs) (5ng each) completely restored 
endocardial cushion formation, cardiac chamber morphogenesis, and even 
restored some blood flow within the heart and major blood vessels in ccm2m201, 
krit1ty219c, and hegm552 mutants (complete rescue was observed for at least n>50 
embryos of each genotype verified by genotyping; high-resolution confocal 
images were recorded for n=5 mutant embryos with invariant results) (Fig. 2C,C’; 
supplementary Fig. S2). That low doses of both MOs were sufficient for the 
rescue of cardiac morphology suggests that Klf2 protein levels are down-
regulated towards normal expression levels by this injection regiment. In 
comparison, the injection of high doses of MOs against either klf2a or klf2b (12ng 
each) did not rescue the cardiac phenotype of ccm2m201 mutants, which shows 
that both Klf2 proteins are involved in the ccm mutant phenotype (Supplementary 
Fig. S2A-H’). Consistent with the previous results, the low-dose knock-down of 
klf2a and klf2b in ccm2m201 mutants rescued endocardial and LDA cell numbers 
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(Fig. 2F,J) and reduced the number of SIV branch points (Fig. 2I,K). Our results 
indicated that the two klf2 genes play a central role in mediating the different 
cardiovascular malformations associated with the loss of CCM proteins. 
To directly examine whether the induction of klf2a in WT embryos was also 
sufficient to phenocopy ccm2m201 mutant cardiovascular defects, we used stable 
transgenic lines for overexpression of klf2a from a friend leukemia integration 1a 
(fli1a) promoter [Tg(fli1ep:GAL4FF)ubs2 (Herwig et al., 2011) and Tg(UAS:klf2a)ig1-
3]. The continuous endothelial-specific overexpression of klf2a in these lines 
begins at endocardial progenitor stages, prior to heart formation, and causes a 
cardiac ballooning phenotype between 48-72 hpf with a high penetrance of ~80% 
(n= 36/43 transgenic embryos out of 3 independent F1 transgenic lines), 
comparable to the ccm2m201mutant cardiac phenotype (Fig. 2L,M). Similarly, 
ubiquitous overexpression of klf2a from a heat-shock promoter induced at 15, 30, 
and again at 38 hpf [Tg(hsp70l:klf2a)md8], resulted in increased LDA cell numbers 
at 48 hpf, comparable to those in ccm2m201 mutants (Fig. 2J). Taken together, the 
overexpression of klf2a/b in zebrafish is necessary and sufficient for the 
expression of cardiovascular malformation phenotypes associated with the loss 
of CCM proteins.  
Klf2 promotes proangiogenic signaling and increases the expression of 
Egfl7  
Several lines of evidence suggest that aberrant angiogenesis may be associated 
with the loss of CCM proteins: Human cerebral cavernous malformations lesion 
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growth is correlated with increased circulating concentrations of VEGF (Jung et 
al., 2003), mice heterozygous for a mutation in CCM2 have increased vascular 
permeability in response to injection of VEGF (Whitehead et al., 2009), and 
angiogenesis signaling is increased in endothelial cells lacking CCM proteins 
(Wustehube et al., 2010; Zhu et al., 2010). In addition, the misregulation of 
angiogenic VEGF signaling has an inhibitory effect on cardiac cushion formation 
in mice (Dor et al., 2001). In agreement with these observations, we found that 
several genes related to angiogenesis signaling were upregulated in ccm2m201 
mutant compared with WT zebrafish cardiac transcriptomes (Table 1).  
To determine whether ccm2m201 mutant cardiovascular defects are due to 
aberrant angiogenesis, we inhibited VEGF signaling in ccm2m201 mutants using 
the pharmacological compound PTK787 (Chan et al., 2002). Under this anti-
angiogenic condition, we observed a rescue of ccm mutant cardiovascular 
defects, including cardiac cushion defects (Fig. 3A-C’) and overproliferation 
defects of endocardium and LDA (Fig. 3D). Based on this evidence, we also 
assayed whether the PTK787 inhibition of angiogenesis would affect klf2a/b 
mRNA levels in ccm2m201 mutants, which is not the case (Fig. 3E). Hence, klf2a/b 
mRNA expression is misregulated independently of VEGFR-mediated 
angiogenesis in ccm2m201 mutants. Taken together, our results indicate that Klf2 
proteins promote proangiogenic signaling.  
Of particular interest among the angiogenesis-related genes that were 
upregulated upon loss of zebrafish Ccm2, was the EGF-like-domain, multiple 7 
(egfl7) gene (Parker et al., 2004), which contains a putative Klf2 binding site 
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(Harris et al., 2010). We verified the increased expression levels of egfl7 in 
ccm2m201 mutants by comparative RT-qPCR (Fig. 4A). To assess whether the 
overexpression of klf2 was sufficient to induce higher levels of egfl7 expression, 
we induced klf2a/b in Tg(hsp70l:klf2a_IRES_EGFP)md8 or 
Tg(hsp70l:klf2b_IRES_EGFP)md9 transgenic embryos and found that, consistent 
with a regulation by klf2 genes, the expression levels of egfl7 mRNA were 
enhanced under this condition (Fig. 4A). Similarly, in HUVECs, levels of EGFL7 
were elevated upon silencing of ICAP1, KRIT1 or CCM2 (Fig. 4B).  
These findings suggested that egfl7 is regulated downstream of Klf2, which 
prompted us to further elucidate its potential involvement in ccm2m201 mutant 
cardiovascular malformations. Strikingly, ccm2m201 mutant cardiovascular 
defects, including the lack of cardiac cushions were rescued upon using a low 
dose of an egfl7MO (0.6ng) (Fig. 4C-E’). Hence, similar to Klf2 proteins, high 
levels of Egfl7 mediate cardiovascular defects associated with the loss of CCM 
proteins. To more directly test whether klf2a/b and egfl7 interact genetically, we 
co-injected klf2a/b (2.5 ng each) and egfl7 MOs (0.3 ng) at low doses that 
individually did not rescue the ccm2m201 mutant cardiovascular phenotypes 
including lumenization defects within intersegmental vessels that arise due to a 
lack of cardiac function (no rescue among n>50 ccm2m201 mutants tested for 
each MO; supplementary Fig. S3D,E). The triple MO injection rescued the 
cardiovascular defects in ccm2m201 mutant embryos as indicated by the 
lumenization of intersegmental vessels (n=19/21 ccm2m201 mutants rescued, 
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verified by genotyping; supplementary Fig. S3C) and further solidified our finding 
that klf2a/b and egfl7 act in a common pathway. 
Contrary to the misregulation of egfl7, neither miR-126a (which is required for 
aortic arch formation in zebrafish) nor miR-126b (which is located within the egfl7 
gene) were misregulated in ccm2m201 mutants based on RT-qPCR experiments 
on 48 hpf whole embryos (Supplementary Fig. S4). Taken together, our results 
indicate that Klf2 proteins promote VEGF-dependent proangiogenic signaling, 
possibly by increasing the expression of Egfl7. 
Overexpression of klf2 within CCM-ICAP1-depleted endothelium involves 
β1 integrin but is independent of blood flow 
Within the zebrafish heart, Klf2a is activated in response to reversible blood flow 
(Vermot et al., 2009). This finding raised the question of whether another 
biophysical force-related mechanism might be involved in the induction of klf2a/b 
in ccm mutants, since they have only severely reduced blood flow. To determine 
whether klf2a/b expression is indeed flow-independent in ccm mutants, we used 
a MO to knock down troponin t2a (tnnt2a). The absence of Tnnt2a causes a loss 
of cardiac contractility due to myofibrillar defects and a complete lack of blood 
flow, which zebrafish embryos survive for several days (Sehnert et al., 2002). We 
found that under such no-flow conditions, ccm2m201 mutant cardiac phenotypes 
(Fig. 5A-C) and elevated klf2a and klf2b mRNA levels were not rescued (Fig. 
5D). Hence, expression levels of klf2a/b mRNA and the occurrence of 
cardiovascular malformations in ccm2m201 mutants are truly independent of the 
mechanical stimulation of ECs by blood flow. Time-lapse analyses between 33-
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53 hpf of ccm2m201 mutant; tnnt2a morphants using light-sheet illumination 
microscopy (SPIM) showed that the Ccm2-deficient endocardium is highly 
proliferative in absence of blood flow, contrary to tnnt2a morphants (Fig. 5E-G; 
supplementary movies 1,2). Similarly, human cerebral cavernoma form in venous 
capillary beds that are characterized by low-blood-flow conditions 
(Supplementary movie 3). Therefore, another stimulus rather than shear stress 
must be involved in the activation of the KLF2 mechanotransduction pathway in 
CCM protein-depleted ECs.  
In HUVECs, ICAP1 directly interacts with and attenuates the activity of β1 
integrin (Millon-Fremillon et al., 2008; Faurobert et al., 2013). Depletion of KRIT1 
causes the destabilization of ICAP1 protein resulting in increased β1 integrin 
activation (Faurobert et al., 2013). In addition, knock-out of ICAP1 in mouse 
leads to vascular defects such as excessive branching and dilation (Faurobert et 
al., 2013). To elucidate the potential involvement of β1 integrin in KLF2-
dependent mechanotransduction, we first used HUVECs to assess KLF2 mRNA 
expression upon simultaneously silencing β1 integrin and either KRIT1, CCM2 or 
ICAP1. We found that β1 integrin was required for high expression levels of KLF2 
mRNA in CCM protein-depleted HUVECs (Fig. 6A; efficacy of siRNA 
knockdowns is shown in supplemental Fig. S5). In a complementary set of 
experiments, we used a MO to downregulate β1b integrin in zebrafish ccm2m201 
mutants (Ablooglu et al., 2010). Remarkably, low doses of β1b integrin MO 
rescued cardiovascular malformations including the loss of cardiac cushions 
(n=5/5 ccm2m201 mutant embryos rescued; Fig. 6B-D’). Taken together, these 
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findings showed that β1 integrin contributes to KLF2 mRNA expression and 
promotes angiogenesis by enhancing Klf2 proangiogenic signaling. These 
findings imply that CCM proteins attenuate angiogenesis signaling during blood 
vessel maturation by negatively modulating the activity of integrins. 
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DISCUSSION 
Our study demonstrates that the shear stress-sensitive transcription factor Klf2 is 
a major player in CCM-dependent vascular development in zebrafish. We found 
that Klf2 is strongly overexpressed independently of blood flow when CCM 
proteins are lost and that 1 integrin is a signal triggering this elevated klf2 
expression. Finally, we suggest that the proangiogenic activity of Klf2 is based on 
the stimulation of Egfl7. These findings identify the CCM complex as a key 
regulator of a novel 1 integrin-Klf2-Egfl7 mechanotransduction pathway in 
zebrafish. This regulation prevents angiogenic overgrowth and ensures the 
quiescence and differentiation of endothelial and endocardial cells. One 
implication of our findings is that extracellular matrix mechanics mediated by 1 
integrin signaling and cellular tension generated within endothelial cells is 
sufficient to activate the mechanosensitive transcription factor Klf2 even in a 
blood-flow-independent manner. The misregulation of cellular tension in ccm 
mutants may cause the developmental defects described in our study. 
Given the current controversy on the functional role of Egfl7 in blood vessel 
development, our work now provides further evidence that expression levels of 
Egfl7 are an important factor in blood vessel development. Initial functional 
studies suggested that loss of egfl7 in mice and zebrafish causes vascular 
defects (Parker et al., 2004; Schmidt et al., 2007). However, in mouse, these 
phenotypes were later attributed to the inactivation of miR-126 within the egfl7 
locus (Kuhnert et al., 2008; Wang et al., 2008). We show here that elevated 
levels of egfl7 in ccm2m201 mutants correlate with abnormal angiogenesis and 
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that down-regulating the expression levels of egfl7 rescues the mutant cardiac 
phenotype. This finding is in tune with a report that overexpression of egfl7 
specifically in endothelial cells induces cardiac and blood vessel defects in mice 
(Nichol et al., 2010). In comparison, miR-126a or miR-126b were not 
misregulated in ccm2m201 mutants. We conclude that the elevated expression 
levels of klf2 and egfl7 mediate the ccm phenotype independently of miR-126.  
Previous studies have not explained why mature, post-angiogenic, and well 
perfused blood vessels are largely resistant to the loss of CCM proteins in mice. 
Instead, the loss of CCM proteins mainly affects low-blood-flow venous capillary 
beds. Our study indicates that KLF2 could be a player in this pathology since it 
controls EC gene expression in response to blood flow with biphasic roles 
depending on the biological context. Within regions of high laminar shear stress, 
the induction of KLF2 establishes vasoprotective gene expression within vessel 
walls (Dekker et al., 2006; Parmar et al., 2006), explaining why high shear-stress 
regions of the human vasculature are mostly protected from cerebral cavernous 
malformation-like lesions. In contrast, lowly-perfused small venous capillary beds 
may be more prone to vascular malformations due to the proangiogenic role of 
KLF2 (Nicoli et al., 2010), which is enhanced by β1 integrin. In support of this 
model, data obtained in constitutive iCCM2 knockout embryonic mice reveal 
strong developmental phenotypes within the cardiovascular system under 
impaired low-flow conditions. Mice targeted post-natally, in which high-flow 
conditions within the heart and arteries have been established, show only 
capillarovenous disease-like phenotypes (Boulday et al., 2011). In principle, low 
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blood flow and hypoxic conditions or proangiogenic stimuli from neighboring 
tissues may enhance a proangiogenic KLF2 response that perpetuates the 
formation of cerebral cavernous malformation lesions. A number of studies have 
suggested that hypoxic conditions in older patients (Denier et al., 2006; Labauge 
et al., 2007) or signaling from neural tissue may trigger the development of 
cerebral cavernous malformation lesions within neighboring venous capillaries 
(Louvi et al., 2011).  
Our work introduces the idea that the CCM complex has an essential role in 
limiting β1 integrin-mediated expression of KLF2 in ECs, thereby attenuating 
VEGF-dependent angiogenesis signaling (Fig. 6E). Future research should 
reveal whether this pathway is relevant for other vascular pathologies as well. 
For instance, genetic and molecular evidence from inheritable forms of 
aneurysms points to an involvement of aberrant TGF-β signaling in these 
vascular diseases (Pardali et al., 2010; Lindsay and Dietz, 2011). Intriguingly, 
murine KLF2 knockout animals frequently present with aortic aneuryms (Kuo et 
al., 1997). Aberrant TGF-β (Pardali et al., 2010; Lindsay and Dietz, 2011; 
Maddaluno et al., 2013) or angiogenesis (Wustehube et al., 2010) signaling is 
found in a plethora of vascular diseases including cerebral cavernous 
malformations. Our work now opens an intriguing possibility that inappropriate 
changes in KLF2 may lie at the heart of many other pathologies of the human 
vasculature both under conditions of low-blood-flow (leading to an enhanced 
proangiogenic KLF2 activity) and also under high-blood-flow (where there is a 
loss of vasoprotective KLF2 activity). 
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EXPERIMENTAL PROCEDURES 
Zebrafish lines and handling. Handling of zebrafish was done in compliance 
with German and Berlin state law, carefully monitored by the local authority for 
animal protection (LaGeSo, Berlin-Brandenburg, Germany). The following strains 
were maintained under standard conditions as previously described (Westerfield 
et al., 1997): ccm2m201 (Mably et al., 2006), krit1ty219c (Mably et al., 2006), hegm552 
(Mably et al., 2003), Tg(myl7:GFP)twu34 (Huang et al., 2003), Tg(kdrl:GFP)s843 (Jin 
et al., 2005), Tg(fli1a:GAL4FF)ubs2 (Herwig et al., 2011), Tg(UAS:KLF2a)ig1-3, 
Tg(hsp70l:klf2a_IRES_EGFP)md8, Tg(hsp70l:klf2b_IRES_EGFP)md9-11. The 
following morpholinos were used: klf2a (GGACCTGTCCAGTTCATCCTTCCAC) 
(Nicoli et al., 2010), klf2b (AAAGGCAAGGTAAAGCCATGTCCAC), tnnt2a 
(CATGTTTGCTCTGATCTGACACGCA) (Sehnert et al., 2002), itgb1b 
(GCCAGTTTGAGTGAATAACTCACCT) (Ablooglu et al., 2010). 
See Supplemental Information for details on morpholino injections, heat-shock 
and pharmacological treatment conditions, and on the generation of transgenic 
lines.  
Immunohistochemistry. For zebrafish whole-mount immunohistochemistry, the 
following antibodies were used: mouse Zn-8/Alcam (1:100; Developmental 
Studies Hybridoma Bank); Cy5-conjugated secondary antibody goat-anti-mouse 
(1:250; Jackson ImmunoResearch Laboratories cat# 96829); Rhodamine 
Phalloidine was used to stain Actin (1:100; Sigma cat# 658740). For details, also 
on quantifications of endocardial and LDA cell numbers, see Supplemental 
Information. 
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Whole-mount in situ hybridizations. Zebrafish embryos were collected at 
48hpf, fixed with 4% paraformaldehyde overnight at 4°C and in situ hybridization 
with klf2a and klf2b in situ probes was performed as described elsewhere (Jowett 
and Lettice, 1994). For details, see Supplemental Information.  
Quantitative RT-qPCR. To determine klf2 expression levels, RT-qPCR 
experiments were performed on zebrafish whole embryos, on iCCM2 mouse 
cerebella (Boulday, 2009), and on HUVECs in compliance with the MIQE 
standard (Bustin et al., 2009). See Supplemental Informations for details on 
samples, conditions and primers used for RT-qPCR, and data analysis. 
Selective plane illumination microscopy (SPIM) imaging. SPIM imaging was 
performed with zebrafish tnnt2a morphants and ccm2m201; tnnt2a 
mutant/morphant embryos harboring the Tg(kdrl:GFP)s843 transgene between 33 
and 53 hpf. See Supplemental Informations for details on samples and analysis 
of the recordings. 
Video angiography during neurosurgical procedures. Video angiography of a 
human cavernoma was performed during a neurosurgical procedure as 
previously described (Raabe et al., 2003). See Supplemental Informations for 
further details. 
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FIGURE LEGENDS 
Fig. 1. Loss of CCM proteins causes elevated levels of klf2 expression. (A-
C) Loss of Ccm2 causes elevated levels of klf2a and klf2b mRNA in zebrafish at 
48 hpf (A), of Klf2 mRNA in mouse cerebellar tissue of iCCM2 mice at P15 (B), 
and of KLF2 mRNA in HUVECs (C) as determined by RT-qPCR. (D-H) At 48 hpf, 
whole-mount in situ hybridizations show that klf2a is misexpressed within the 
entire endocardium of krit1ty219c and ccm2m201 mutants (D-F) and is elevated 
within arteries and veins in the tail region (asterisk) of ccm2m201 mutants (G-H). 
Statistical data are means and s.e.m.; *, p<0.05, **, p<0.01; ***, p<0.001; ****, 
p<0.0001; see supplemental information for details about statistical data analysis.  
Fig. 2. Elevated levels of klf2 mRNA cause morphogenetic defects in 
zebrafish ccm mutants. (A-I) Rescue of cardiac malformations, lateral dorsal 
aorta (LDA) defects, and subintestinal vein (SIV) defects in zebrafish ccm2m201 
mutants (B,B’,E,H) by targeting klf2a/b with MOs (C,C’,F,I). (A-C) Shown are 
hearts of different genotypes at 48 hpf or (A’,B’,C’) details with single confocal 
plane sections of the atrioventricular canal (AVC) region (arrowheads) (white 
box). Endocardial cushion cells are marked by Tg(kdrl:GFP)s843 and Alcam 
staining (asterisks). (D-F) Dorsal views of the LDA marked by Tg(kdrl:GFP)s843 
(inverted images) in different genotypes at 48 hpf. (G-I) Side view of the SIV 
marked by Tg(kdrl:GFP)s843 in different genotypes at 72 hpf. Vessel branch point 
defects (arrows) within the SIV are reduced by targeting klf2a/b in ccm2m201 
mutants (H,I). (J) Endocardial and LDA cell numbers are elevated in ccm2m201 
mutants at 48 hpf, as well as upon overexpression of klf2a from a heat-shock 
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inducible promoter. (K) Quantifications of the number of branchpoints of the SIV 
in different genotypes at 72 hpf. (L,M) Endothelial overexpression of klf2a in 
Tg(fli1ep:Gal4FF)ubs2; Tg(UAS:KLF2a)ig1-3 ; Tg(kdrl:GFP)s843 transgenic embryos 
is sufficient to phenocopy the ccm2m201 mutant cardiac ballooning phenotype. 
endo, endocardium; myo, myocardium; A, atrium; V, ventricle. Scale bars are all 
25µm. Statistical data are means and s.e.m.; ns, not significant; *, p<0.05; **, 
p<0.01; ***, p<0.001; ****, p<0.0001; see supplemental information for details 
about statistical data analysis.  
Fig. 3. Enhanced VEGFR signaling is involved in the zebrafish ccm2m201 
mutant cardiac phenotype. (A-C) Rescue of cardiac malformations in ccm2m201 
mutants at 48 hpf after treatment with the VEGFR inhibitor PTK787 between 15-
17 hpf. (A-C) Shown are hearts marked by endocardial Tg(kdrl:GFP)s843 and 
Actin staining at 48 hpf or (A’,B’,C’) details with single confocal plane sections of 
the AVC region  (white box in A,B,C). Endocardial cushion cells are 
characterized by their cuboidal shape and cortical Actin (asterisks) (n=5/5 
genotyped ccm2m201 mutants completely rescued by PTK787 treatment). (D) 
Treatment of ccm2m201 mutants with PTK787 between 15-17 hpf significantly 
reduces the endocardial overproliferation phenotype and treatment between 24-
48 hpf suppresses the overgrowth of the LDA. (E) The phenotypic rescue of 
ccm2m201 mutants by treatment with PTK787 between 15-48 hpf does not affect 
the elevated expression levels of klf2a and klf2b as detected by RT-qPCR. endo, 
endocardium; myo, myocardium. Scale bars are all 25µm. Statistical data are 
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means and s.e.m.; ns, not significant; *, p<0.05; **, p<0.01; ***, p<0.001; ****, 
p<0.0001; see supplemental information for details about statistical data analysis.  
Fig. 4. Elevated expression levels of egfl7 mRNA are involved in the 
ccm2m201 mutant phenotype. (A) Loss of Ccm2 or overexpression of klf2a/b in 
Tg(hsp70l:klf2a_IRES_EGFP)md8  or Tg(hsp70l:klf2b_IRES_EGFP)md9 transgenic 
embryos causes elevated levels of egfl7 mRNA as determined by RT-qPCR. (B) 
Similarly, EGFL7 is upregulated in HUVECs upon knock-down of ICAP1, KRIT1, 
or CCM2 by siRNA treatment. (C-E’) Cardiac morphology and cardiac cushion 
formation are rescued by egfl7 MO injection (n=15/15 genotyped ccm2m201 
mutants completely rescued by egfl7 MO). Shown are hearts marked by 
endocardial Tg(kdrl:GFP)s843 and Actin staining at 48 hpf or (C’-E’) details with 
single confocal plane sections of the AVC region. Endocardial cushion cells are 
marked by the expression of Alcam (inverted image) (asterisks). Scale bars are 
all 25µm. Statistical data are means and s.e.m.; *, p<0.05; **, p<0.01; ***, 
p<0.001; see supplemental information for details about statistical data analysis.  
Fig. 5. Blood flow-independent expression of klf2a/b mRNA in ccm2m201 
mutants. (A-C) The ccm2m201 mutant cardiac ballooning phenotype is flow-
independent. Frontal views of 48hpf hearts of the myocardial reporter line 
Tg(myl7:GFP)twu34 (Huang et al., 2003) show that cardiac expansion is not 
rescued in ccm2m201 mutant; tnnt2a morphants that lack blood flow. (D) The 
expression levels of klf2a and klf2b mRNA as measured by RT-qPCR are 
elevated in ccm2m201 mutant; tnnt2a morphants that lack blood flow. (E-G) Loss 
of Ccm2 results in overproliferation of the endocardium under no-flow conditions. 
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(E) Quantifications of the ratio of proliferating versus non-proliferating 
endocardial cells between 33-53 hpf in tnnt2a morphants compared with 
ccm2m201 mutant;tnnt2a morphants based on SPIM recordings (n=2). (F) The 
endocardium of tnnt2a morphants is not proliferative as indicated by the lack of 
color-coded proliferative cells [still image derived from supplementary movie S1, 
which is based on SPIM timelapse recordings of endocardial morphogenesis 
marked by Tg(kdrl:GFP)s843 between 33-53 hpf]. (G) The combined loss of Ccm2 
and Tnnt2a is characterized by a high rate of proliferative events (indicated by 
uniquely colored daughter cells derived from proliferative events; still image 
derived from supplementary movie S2). A, atrium; V, ventricle. Statistical data 
are means and s.e.m.; ns, not significant; *, p<0.05; **, p<0.01; ***, p<0.001; ****, 
p<0.0001; see supplemental information for details about statistical data analysis. 
Fig. 6. Misexpression of KLF2 depends on integrin β1. (A) RT-qPCR  shows 
that elevated expression of KLF2 mRNA in ICAP1-, KRIT1-, or CCM2-silenced 
HUVECs is partly suppressed upon simultaneously interfering with β1 integrin 
(ITGB1). (B-D) Morpholino knockdown of zebrafish integrinβ1b completely 
restores cardiac morphology [marked by Tg(kdrl:GFP)s843 and Actin staining]  
and cardiac cushion formation in zebrafish ccm2m201 mutants at 48hpf. (B’-D’) 
Shown are single confocal plane sections with details of the atrioventricular canal 
(AVC) region (white box in B-D) with endocardial cushion cells are marked by 
Alcam (asterisks). (E) Model of CCM/ICAP1 controlled proangiogenic activity of 
the β1 integrin-Klf2 mechanotransduction pathway. endo, endocardium; myo, 
myocardium. Scale bars are all 25µm. Statistical data are means and s.e.m.; ns, 
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not significant;***, p<0.001; ****, p<0.0001; see supplemental information for 
details about statistical data analysis. 
Table 1: Upregulation of angiogenesis-related gene expression in ccm2m201 
mutants. List of angiogenesis-related genes up-regulated in ccm2m201 cardiac 
tissue at 72hpf compared with wild-type. The two klf2 homologous genes are 
marked in grey.    
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INVENTORY OF SUPPLEMENTAL INFORMATION 
1. Figs. S1 to S5 
2. Movies 1-3 
3. Experimental Procedures 
4. References for Experimental Procedures 
 
 Figure S1, related to Figure 1, shows endocardial misexpression of klf2b in krit1ty219c 
and ccm2m201 mutants (related to main Figure 1D-F). 
 Figure S2, related to Figure 2, shows that the cardiac malformation phenotypes in 
ccm2m201, krit1ty219c, and hegm552 mutants are rescued by targeting klf2a/b with MOs. 
Targeting of either klf2a or klf2b in ccm2m201 mutants does not rescue cardiac 
phenotypes (related to main Figure 2A-C). 
 Figure S3, related to Figure 4, shows that coinjection of egfl7 and klf2a/b 
morpholinos rescues the cardiovascular phenotype of ccm2m201 mutants.  
 Figure S4, related to Figure 4, shows that miR-126a and miR-126b levels are 
unchanged in ccm2m201 mutants. 
 Figure S5, related to Figure 6, shows that siRNA treatment in HUVECs efficiently 
lowers protein levels of CCM2, KRIT1, ICAP1, or ITGB1, respectively. 
 Movies 1 and 2, related to main Figure 5, are selective plane illumination microscopy 
timelapse movies of endocardial development between 33-53hpf in tnnt2a morphants 
that lack blood flow (Movie 1) and tnnt2a morphants;ccm2m201 mutants (Movie 2) 
(related to Figure 5E-G).  
 Movie 3, related to Figure 5, is a microangiography of a human brain with a 
cavernous malformation and shows that the cavernoma region is characterized by 
low blood perfusion. 
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1. SUPPLEMENTARY FIGURES 
Fig. S1. Endocardial expression of klf2b mRNA is misregulated in zebrafish ccm 
mutants. (A) Whole-mount in situ hybridization reveals that klf2b is expressed at the 
atrioventricular canal (AVC) at 48 hpf in WT. (B,C) Loss of Krit1 or of Ccm2 causes 
elevated expression of klf2b throughout the entire ballooning endocardium. 
Fig. S2. Rescue of cardiac cushions in ccm2m201 , hegm552, and krit1ty219c mutants 
by knockdown of Klf2a/b. (A,C,E,G,I,K,M) Shown are hearts of different genotypes 
marked by the endothelial reporter line Tg(kdrl:GFP)s843 counterstained with Alcam, or 
Actin staining alone (inverted image). (B,D,F,H,J,L,N) Details show single confocal 
planes of the atrioventricular canal (AVC) region. Endocardial cushion cells (asterisks) 
are marked by Tg(kdrl:GFP)s843 and Alcam staining, or Alcam staining only (inverted 
images). Whereas knockdown of only Klf2a (E,F) or Klf2b (G,H) does not rescue cardiac 
morphogenesis or the number of endocardial cushions cells in ccm2m201 mutants, 
knockdown of both Klf2 proteins completely restores cardiac morphology and cardiac 
cushion formation (I,J). (K-N) Similarly, hegm552 and krit1ty219c mutants are completely 
rescued by the knockdown of Klf2a/b (n=5/5 of either mutant completely rescued). endo, 
endocardium; myo, myocardium; A, atrium; V, ventricle. 
Fig. S3. Klf2a/b and Egfl7 interact to regulate lumen formation of intersegmental 
blood vessels. Compared to wild-type (A), the intersegmental vessels of ccm2m201 
mutants (B) are not lumenized. Injection of ccm2m201 mutants with low doses of egfl7 MO 
(D; n>50/50) or klf2a/b MO (E; n>50/50) does not rescue the lumenization defects within 
intersegmental vessels. In contrast, co-injection of klf2a/b MOs and egfl7 MO into 
ccm2m201 mutants (C) completely rescues lumenization defects (n=19/21 mutants 
identified by genotyping). Red arrows: lumenized intersegmental vessels; orange 
arrows: non-lumenized intersegmental vessels. Scale bars are all 50µm. 
Fig. S4. miR-126a and miR-126b are normally expressed in ccm2m201 mutants.  RT-
qPCR experiments revealed that neither miR-126a nor miR-126b levels are significantly 
changed in ccm2m201 mutant embryos at 48hpf. Statistical data are means and s.e.m.; 
ns, not significant; see supplemental information for details about statistical data 
analysis. 
Fig. S5. Western blot analysis of CCM protein levels in HUVECs upon siRNA 
silencing. CCM2, KRIT1 and ICAP1 protein levels are reduced upon CCM2, KRIT1 and 
ICAP1 siRNA treatment, respectively. Similarly, ITGB1 levels are reduced upon ITGB1 
siRNA treatment. Actin levels are shown as a loading control. 
2. SUPPLEMENTARY MOVIES 
Supplementary Movie 1. Selective plane illumination microscopy (SPIM) timelapse 
movie of zebrafish endocardial cell proliferation under no-blood flow conditions 
between 33-53 hpf. Selective plane illumination microscopy (SPIM) timelapse movie 
shows that the knockdown of Tnnt2a, which causes no-flow conditions within the heart, 
is characterized by low levels or no proliferation as indicated by the endothelial reporter 
line Tg(kdrl:GFP)s843 (see Figure 5E,F). 
Supplementary Movie 2. Selective plane illumination microscopy (SPIM) timelapse 
movie of zebrafish endocardial cell proliferation under no-blood flow conditions 
and loss of Ccm2 between 33-53 hpf. Combined knockdown of Ccm2 and Tnnt2a 
results in a high rate of proliferative events as indicated by the endothelial reporter line 
Tg(kdrl:GFP)s843. Nuclei of proliferative cells are color coded during mitosis and remain 
uniquely colored throughout the recording (see Figure 5E,G). 
Supplementary Movie 3. Angiography of human brain with a cavernous 
malformation. Perfusion with a contrast reagent shows that the cavernoma region is 
characterized by low blood perfusion. 
3. SUPPLEMENTARY EXPERIMENTAL PROCEDURES  
Gateway cloning of transgenesis constructs. The open reading frames of zebrafish 
klf2a (NM_131856) (Vermot et al., 2009) or zebrafish klf2b (NM_131857) were amplified 
by PCR and cloned into the Gateway pDONR 221 vector (Kwan et al., 2007; Villefranc 
et al., 2007) (referred to as pME-klf2a or pME-klf2b; primer sequences available upon 
request). The following final constructs were generated by standard Gateway cloning 
reactions with pDestTol2, p5E-UAS or p5E-hsp70l, pME-klf2a or pME-klf2b, and p3E-pA 
or p3E-IRES_EGFP: 
UAS:klf2a 
hsp70l:klf2a_IRES_EGFP 
hsp70l:klf2b_IRES_EGFP 
Generation of transgenic lines of zebrafish. Each of the transformation  plasmids was 
coinjected with the Tol2 transposase capped mRNA synthetised using the SP6 
polymerase (mMessage Machine, Ambion) into one-cell stage zebrafish embryos. 
Several independent transgenic lines were established for each construct. In functional 
tests, these independent lines resulted in comparable phenotypes. 
Zebrafish lines and handling. Handling of zebrafish was done in compliance with 
German and Berlin state law, carefully monitored by the local authority for animal 
protection (LaGeSo, Berlin-Brandenburg, Germany). The following strains were 
maintained under standard conditions as previously described (Westerfield et al., 1997): 
ccm2m201 (Mably et al., 2006), krit1ty219c (Mably et al., 2006), hegm552 (Mably et al., 2003), 
Tg(myl7:GFP)twu34 (Huang et al., 2003), Tg(kdrl:GFP)s843 (Jin et al., 2005), 
Tg(fli1a:GAL4FF)ubs2 (Herwig et al., 2011), Tg(UAS:klf2a)ig1-3, 
Tg(hsp70l:klf2a_IRES_EGFP)md8, Tg(hsp70l:klf2b_IRES_EGFP)md9-11.  
Heat-shock experiments. For the experiment shown in Fig. 2J, 
Tg(hsp70l:klf2a_IRES_EGFP)md8 embryos were heat-shocked three times: at the 11-
somite stage (30min at 37°C), then at 24hpf (40min at 38°C), and at 40hpf (45min at 
38°C). Alternatively, for the experiment shown in Fig. 4A, 
Tg(hsp70l:klf2a_IRES_EGFP)md8 and Tg(hsp70l:klf2b_IRES_EGFP)md9 embryos were 
heat-shocked only once at 24hpf (40min at 38°C) . 
Morpholino injections. Embryos were injected at the one-cell stage with the following 
morpholinos as previously described:  
morpholino 
name morpholino sequence 
Amount 
/ embryo Ref. 
klf2a ATG 5‘-GGACCTGTCCAGTTCATCCTTCCAC-3‘ 12ng (Nicoli et al., 2010) 
klf2b ATG 5‘-AAAGGCAAGGTAAAGCCATGTCCAC-3‘ 12ng - 
5ng klf2aMO + 5ng klf2bMO 
egfl7 ATG 5‘-CAGGTGTGTCTGACAGCAGAAAGAG-3‘ 650pg (Parker et al., 2004) 
2,5ng klf2aMO + 2,5ng klf2bMO + 0,3ng egfl7MO 
tnnt2a ATG 5‘-CATGTTTGCTCTGATCTGACACGCA-3‘ 2ng (Sehnert et al., 2002) 
itgb1b splice 5‘-GCCAGTTTGAGTGAATAACTCACCT-3‘ 6.3ng (Ablooglu et al., 2010) 
 
Pharmacological treatment. Embryos were treated in E3 medium with 12,5M of 
VEGFR inhibitor PTK787 (Chan et al., 2002). Control embryos were treated with 0,01% 
DMSO. Treatment protocols corresponding with different figures were as follows:  
1). between 15-17hpf (shown in Fig. 3C,C’; Fig. 3D – only endocardium) 
2). between 24-48hpf (shown in Fig. 3D – only LDA; Fig. 3E) 
Immunohistochemistry. Zebrafish whole-mount immunohistochemistry was performed 
on 48 hpf embryos as previously described (Veerkamp et al., 2013) The following 
antibodies were used: mouse Zn-8/Alcam (1:100; Developmental Studies Hybridoma 
Bank)(Beis et al., 2005); Cy5-conjugated secondary antibody goat-anti-mouse (1:250; 
Jackson ImmunoResearch Laboratories cat# 96829); Rhodamine Phalloidine was 
incubated in combination with the secondary antibody to stain Actin (1:100; Sigma cat# 
658740). Images were recorded at a LSM710 confocal microscope (Zeiss) and 
processed with Adobe Photoshop (Adobe Systems). 
Statistical analysis of endocardial and lateral dorsal aorta cell numbers. In Figure 
2J and Figure 3D, nuclei were visualized by Tg(kdrl:GFP)s843 expression and were 
counted within the heart (for endocardium), or in both lateral dorsal aortae in an area 
defined between the branching point from the dorsal aorta and the branching point of the 
first aortic arch. Cell numbers are shown as means with S.E.M. Prism 5 (GraphPad) was 
used to perform 1-way ANOVA tests followed by Sidak’s multiple comparisons tests 
(Fig. 2J, 3D). Means are statistically significantly different when P < 0.05. 
 Endocardium n= Average cell number S.E.M. 
WT 3 144,7 1,202 
WT + PTK787 3 146,7 14,52 
ccm2 3 205,3 6,692 
ccm2 + PTK787 4 162,5 3,797 
ccm2;klf2abMO 3 131 2,082 
 
 1-way ANOVA P value 
Fig. 2J, 
endocardium 
wt vs ccm2 ***  P=0,0001 
wt vs ccm2;klf2abMO n.s.  P=0,1607 
ccm2 vs ccm2;klf2abMO ****  P<0,0001 
Fig. 3D, 
endocardium 
wt vs ccm2 **  P=0,0022 
wt vs wt + PTK787 n.s. P>0.9999 
wt vs ccm2 + PTK787 n.s. P=0,4871 
wt + PTK787 vs ccm2 + PTK787 n.s. P=0,5999 
ccm2 vs ccm2 + PTK787 *   P=0,0141 
 
 LDA n= Average cell number S.E.M. 
WT 3 57,6 1,453 
ccm2 3 83 1,528 
ccm2;klf2abMO 2 56,5 3,5 
hsp70l:klf2a 2 88,5 4,5 
ccm2 + PTK787 3 62 1,53 
 
 1-way ANOVA P value 
Fig.2J, 
LDA 
wt vs ccm2 **  P=0,0011 
wt vs ccm2;klf2abMO n.s. P=0,9991 
wt vs hsp70l:klf2a *** P=0,0007 
ccm2 vs hsp70l:klf2a n.s. P=0,6158 
ccm2 vs ccm2;klf2abMO ** P=0,0015 
Fig.3D, 
LDA 
wt vs ccm2 ****  P<0,0001 
wt vs ccm2 + PTK787 n.s. P=0,2405 
ccm2 vs ccm2 + PTK787 ***  P=0,0002 
 
Statistical analysis of subintestinal vein (SIV) branchpoints. In Figure 2K, SIV were 
visualized at 72 hpf by Tg(kdrl:GFP)s843 expression and branchpoints were counted. 
Branchpoint numbers are shown as means with S.E.M. Prism 5 (GraphPad) was used to 
perform a 1-way ANOVA test followed by Sidak’s multiple comparisons test. Means are 
statistically significantly different when P < 0.05. 
 n= Average number of branchpoints S.E.M. 
WT 10 9,6 0,371 
ccm2 10 12,3 0,882 
ccm2;klf2abMO 5 8,2 0,583 
 
 1-way ANOVA P value 
Fig. 2K 
wt vs ccm2 *  P=0,0198 
wt vs ccm2;klf2abMO n.s.  P=0,5214 
ccm2 vs ccm2;klf2abMO **  P=0,0036 
 
Whole-mount in situ hybridizations. Zebrafish embryos were collected at 48hpf and 
fixed with 4% paraformaldehyde overnight at 4°C. The klf2a and klf2b antisense mRNA 
in situ probes were generated by PCR amplification from 24hpf WT cDNA (primers 
available upon request). The amplicons were cloned into the pSC-B vector with the 
StrataClone Blunt PCR Cloning kit (Stratagene). Antisense RNA was synthesized using 
the DIG RNA Labeling kit (Roche). In situ hybridization was performed as described 
elsewhere (Jowett and Lettice, 1994). After staining, the embryos were dehydrated in 
Benzylbenzoate and mounted in Permount for imaging. Images were recorded at an 
Axioplan2 microscope (Zeiss) and processed with Adobe Photoshop software (Adobe 
Systems). 
HUVECs cell culture and transfection. HUVEC were obtained from Lonza and grown 
in EBM-2 media supplemented with 100U/ml penicillin / 100 µg/ml streptomycin at 37°C 
in a 5% CO2-humidified chamber according to manufacturer’s instructions. HUVEC 
(1.5x106 cells) were transfected twice at 24h interval with 20 nM siRNA and 45 µl 
lipofectamine RNAi max (Invitrogen) according to manufacturer’s instructions. Cells were 
used the day after the second round of transfection. For silencing of ß1 integrin, at least 
3 rounds of transfection were performed. Control conditions are mock transfections. 
KRIT1 and ITGB1 siRNA are siGENOME smart pool (Dharmacon) and CCM2 siRNA is 
ON-TARGET smart pool (Dharmacon). ICAP-1 custom siRNA (Eurogentec) sequence is 
GCAUGCUCUCUACUUAAUA.  
Western blot analysis of CCM proteins content in HUVECs upon siRNA silencing. 
siRNA transfected HUVEC were lysed in laemmli buffer the day after the last round of 
transfection, run on SDS-PAGE and transferred on PVDF membrane. Immunological 
detection was achieved as in Faurobert et al. (2013). Peroxidase activity was visualized 
by ECL (Clarity, BIORAD laboratories) using a ChemiDoc MP imaging system (BIORAD 
laboratories). 
iCCM2 mice. Endothelial-specific conditional CCM2 knock-out mice Cadh5(PAC)-
CreERT2/+; Ccm2 Fl/Del., referred to as iCCM2, were treated with Tamoxifen at post-natal 
day 1 (P1) to induce the endothelial specific deletion of Ccm2 (Boulday et al., 2009). 
Cadh5(PAC)-CreERT2/+ mice were treated identically and used as controls. Mice were 
sacrificed at P15, the brains were prepared, snap-frozen, and the cerebella (in iCCM2 
mice, these harbor cavernomas) were subsequently isolated for RNA extraction.  
Quantitative RT-qPCR for miR-126a/b in zebrafish. Total RNA was isolated from 50 – 
100 whole zebrafish embryos 48 hours post fertilization using Trizol (Invitrogen). For 
reverse transcription reaction 1µg total RNA was used in miScript RT-kit purchased from 
Qiagen. RT-qPCR Primers specific for miR-126a (MSC0074644) and miR-126b 
(MSC0074645) were purchased from Qiagen and RT-PCR was performed using the 
miScript SYBR Green PCR Kit (Qiagen). RNU6 was used to normalize the miR-126a/b 
levels. 
Quantitative RT-qPCR. RT-qPCR experiments were performed on zebrafish whole 
embryos, on P15 mouse cerebella, and on HUVECs in compliance with the MIQE 
standard (Bustin et al., 2009). For zebrafish, up to 25 embryos were pooled for each 
condition at 48hpf, or at 30hpf (in the case of heat-shocked fish; Fig. 4A). Zebrafish 
tissues were collected several times from independent experiments and therefore 
represent biological replicates. For the RT-qPCR experiment performed with iCCM2 
mouse tissues shown in Fig. 1B, total mRNA was extracted with Trizol (Sigma) from the 
cerebella of 5 mice per group. For mouse and zebrafish samples, cDNA was 
synthesized from total RNA with Moloney murine leukemia virus reverse transcriptase 
(Invitrogen) using random hexamer nucleotides, and RT-qPCR experiments were 
performed as described (Veerkamp et al., 2013) using 6ng cDNA. The amplicon size 
was verified on agarose gels. For HUVECs, quantitative real-time PCR was performed 
with iTaqTM Universal SYBR Green Supermix (Bio-Rad) in a 25 µl reaction on a C-1000 
Touch Thermal Cycler (BIORAD). Product sizes were controlled by DNA gel 
electrophoresis and the melt curves were evaluated using the BioRad CFX Manager. Ct-
values were determined with the same software. The following primers were used for 
RT-qPCR: 
 Primer name Primer sequence UniGene identifier 
hu
m
an
 
For_KLF2 5‘-CATCTGAAGGCGCATCTG-3‘ Hs.744182 
Rev_KLF2 5‘-CGTGTGCTTTCGGTAGTGG-3‘ 
For_EGFL7 5‘-GTGGACCTGCTGGAGGAGAA-3‘ Hs.91481  
Rev_EGFL7 5’-TCCGGGAGCCCATGCT-3’ 
For_ATP5O 5‘-ATTGAAGGTCGCTATGCCACAG-3‘ Hs.409140 
Rev_ATP5O 5‘-AACAGAAGCAGCCACTTTGGG-3‘ 
m
ou
se
 Klf2Mm_fwd 5‘-AGGAGCGCTGGCCGCGAAAT-3‘ Mm.26938 
Klf2Mm_rev 5‘-GGCGCCCAGACCGTCCAATC-3‘ 
Eif1Mm_fwd 5‘-ATGGTACTGTAATTGAGCATCC-3‘ 
Mm.13886 
Eif1Mm_rev 5‘-GTGACAAGGGACAGAAGGGAAA-3‘ 
ze
br
af
is
h 
Klf2aDr_fwd 5‘-CTGGGAGAACAGGTGGAAGGA-3‘ 
Dr.29173 
Klf2aDr_rev 5‘-CCAGTATAAACTCCAGATCCAGG-3‘ 
Klf2bDr_fwd 5‘-GGATAGATGGAAGATTGAGGAGCA-3‘ 
Dr.9976 
Klf2bDr_rev 5‘-CTCCAGGTCTAAATAATTGCTGAG-3‘ 
Egfl7_fwd 5‘-TTTACCCAGAATGCTGTCCG-3‘ 
Dr.89996 
Egfl7_rev 5‘-AAAACTGCCCAGCGTATTCA-3‘ 
Eif1bDr_fwd 5‘-CAGAACCTCCAGTCCTTTGATC-3‘ 
Dr.162048 
Eif1bDr_rev 5‘-GCAGGCAAATTTCTTTTTGAAGGC-3‘ 
RT-qPCR data analyses. Results were analyzed using the comparative threshold cycle 
(Ct) method (2–Ct) to compare gene expression levels between samples as previously 
described (Livak and Schmittgen, 2001). As internal reference genes, we used zebrafish 
eif1b, mouse EIF1, and for HUVECs normalization was done with the house keeping 
genes GAPDH, RELA or ATP5O, yielding comparable results. Expression levels of each 
target gene in the siRNA –treated HUVECs were calculated with ATP5O as reference 
gene and compared to control. The RT-qPCR experiments with HUVECs shown in 
Figure 1C were performed 4 times; the results of the RT-qPCR experiments shown in 
Figure 4B and 6A are representative of more than 3 experiments. The mRNA expression 
levels of klf2a, klf2b, egfl7 (zebrafish), Klf2 (mouse), and KLF2 (HUVECs) are shown as 
relative mean values with S.E.M. The statistical analysis was done with Prism 5 
(GraphPad) to perform unpaired t-tests (zebrafish in Fig. 1A, 4A; mouse in Fig. 1B), a 
paired t-test (HUVECs in Fig. 1C), 1-way ANOVA tests followed by Sidak’s multiple 
comparisons tests (zebrafish in Fig. 3E, 5D), or 1-way ANOVA tests with Dunnett’s 
Multiple Comparison Test (zebrafish in Fig. 4A, HUVECs in Fig. 4B and 6A). Means are 
statistically significantly different if P < 0.05. 
zebrafish n= 
klf2a klf2b egfl7 
Mean SEM Mean SEM Mean SEM 
Fig. 1A 
wt 4 1,002 0,033 1,004 0,052 - - 
ccm2 5 1,779 0,073 1,740 0,046 - - 
Fig. 3E 
wt 3 1,001 0,029 1,002 0,043 - - 
ccm2 3 1,796 0,248 1,725 0,173 - - 
wt + PTK787 3 0,925 0,030 1,054 0,062 - - 
ccm2 + PTK787 3 1,713 0,163 1,666 0,039 - - 
Fig. 4A 
wt 3 - - - - 1 0,017 
ccm2 3 - - - - 1,335 0,070 
Fig. 4A 
Heat-shock control 3 - - - - 1,001 0,034 
hsp70l:klf2a_IRES_GFP 3 - - - - 1,477 0,058 
hsp70l:kfl2b_IRES_GFP 3 - - - - 1,9 0,14 
Fig. 5D 
wt 4 1,002 0,033 1,004 0,052 - - 
tnnt2aMO 5 0,740 0,046 0,831 0,040 - - 
ccm2 5 1,779 0,073 1,740 0,046 - - 
ccm2 + tnnt2aMO 4 1,804 0,051 1,343 0,023 - - 
 
 Unpaired t-test (Fig.1A, 4A); 1-way ANOVA (Fig. 3E, 4A, 5D) 
P value 
klf2a klf2b egfl7 
Fig. 
1A wt vs ccm2 **** P<0,0001 **** P<0,0001 - 
Fig. 
3E 
wt vs ccm2 * P=0,0225 ** P=0,0029 - 
wt vs wt + PTK787 n.s. P=0,994 n.s. P=0,993 - 
wt vs ccm2 + PTK787 * P=0,0395 ** P=0,0050 - 
ccm2 vs ccm2 + PTK787 n.s. P=0,992 n.s. P=0,989 - 
Fig. 
4A wt vs ccm2 - - **  P=0,0098 
Fig. 
4A 
ctrl vs hsp70l:klf2a_IRES_GFP - - *  P=0,017 
ctrl vs hsp70l:klf2b_IRES_GFP - - ***  P=0,0007 
Fig. wt vs tnnt2aMO * P=0,0257 n.s. P=0,063 - 
5D wt vs ccm2 **** P<0,0001 **** P<0,0001 - 
wt vs ccm2;tnnt2aMO **** P<0,0001 *** P=0,0006 - 
tnnt2aMO vs ccm2;tnnt2aMO **** P<0,0001 **** P<0,0001 - 
ccm2 vs ccm2;tnnt2aMO n.s. P=0,999 **** P<0,0001 - 
 
mouse n= 
Klf2 Unpaired t-test 
Mean SEM Significant? P<0,05? 
Fig 1B 
control 5 1,009 0,0661 ** 
P=0,0023 iCCM2 5 1,690 0,1407 
 
HUVECs n= 
KLF2 EGFL7 
Mean SEM Mean SEM 
Fig. 
1C  
Control 4 1 0 - - 
siRNA-CCM2 4 16,93 4,247 - - 
Fig. 
4B 
Control siRNA 2 - - 1 0,023 
siRNA-ICAP1 2 - - 2,897 0,646 
siRNA-KRIT1 2 - - 6,432 0,213 
siRNA-CCM2 2 - - 5,428 0,249 
Fig. 
6A 
Control siRNA 3 1,003 0,052 - - 
siRNA-ICAP1 3 4,582 0,548 - - 
siRNA-KRIT1 3 4,386 0,198 - - 
siRNA-CCM2 3 5,291 0,053 - - 
siRNA-ITGB1 3 1,002 0,041 - - 
siRNA-ICAP1 + siRNA-ITGB1 3 1,054 0,069 - - 
siRNA-KRIT1 + siRNA-ITGB1 3 0,914 0,221 - - 
siRNA-CCM2 + siRNA-ITGB1 3 1,393 0,103 - - 
 
 Paired t-test (Fig. 1C) and 1-way ANOVA test (Fig. 4B, 6A) 
P value 
KLF2 EGFL7 
Fig. 1C control vs siRNA-CCM2 *   P=0,0331 - 
Fig. 
4B 
control vs siRNA-ICAP1 - *  P=0,0467 
control vs siRNA-KRIT1 - **  P=0,0010 
control vs siRNA-CCM2 - **  P=0,0023 
Fig. 
6A 
control vs siRNA-ICAP1 **** P<0,0001 - 
control vs siRNA-KRIT1 *** P=0,0001 - 
control vs siRNA-CCM2 **** P<0,0001 - 
siRNA-ITGB1 vs siRNA-ICAP1 + siRNA-ITGB1 n.s. P=0,982 - 
siRNA-ITGB1 vs siRNA-KRIT1 + siRNA-ITGB1 n.s. P=0,931 - 
siRNA-ITGB1 vs siRNA-CCM2 + siRNA-ITGB1 n.s. P=0,147 - 
 
Heart extraction and microarray analyses. Entire hearts were extracted from wild-type 
and ccm2m201 mutant zebrafish embryos at 72 hpf by manual dissection as described 
elsewhere (Burns and MacRae, 2006). Total RNA was extracted with the RNeasy Micro 
Kit (Qiagen) according to the manufacturer’s instructions. RNA quality was assessed on 
a 2100 Bioanalyzer RNA 6000 Nano chip (Agilent Technologies). RNA processing and 
chip hybridization was performed by imaGenes GmbH (Berlin, Germany) according to 
Agilent standard procedures. In brief, for each sample, 200ng of total RNA was 
subjected to a single amplification step and Cy3 labeling reaction. 1,5 μg of labeled 
cRNA were hybridized to Zebrafish (V2) Gene Expression Microarrays (G2519F-
019161, 4x44K) and spot intensities recorded on a G2565BA scanner (Agilent 
Technologies). Microarrays were performed in single replicates for WT and ccm2m201 
samples. Raw expression values were adjusted in R (www.r-project.org) using variance 
stability normalization (Huber et al., 2002). Enriched biological processes were identified 
by performing a functional annotation clustering analysis on DAVID (Huang et al., 2009). 
Only the most relevant terms were considered at significant p-values (p<0.05). 
Selective plane illumination microscopy (SPIM) imaging. Timelapse data were 
recorded on a SPIM setup as described before (Huisken and Stainier, 2009). Transgenic 
zebrafish Tg(kdrl:GFP)s843 embryos were dechorionated at 24 hpf, anesthetized with 
Tricaine (200mg/L, Aldrich) and mounted in FEP fluorinated propylene ethylene (FEP) 
tubes filled with 3% methyl cellulose (Kaufmann et al., 2012). Between 33-53hpf, 
embryos were imaged every three minutes. Cell positions were tracked manually based 
on maximal intensity projections using the Wand and the Flood Fill Tool in Fiji 
(Schindelin et al., 2012). The ratio of proliferative vs. non-proliferative endocardial cells 
was determined based on these recordings and is shown as mean with SEM. Each 
dividing cell and its daughter cell were assigned a unique color to visualize mitotic 
events. The statistical analysis was performed in Prism 5 (GraphPad) as an unpaired t-
test. Means are statistically significantly different if P < 0.05. 
 
 
 
embryo 
Number of 
(tracked) cells 
undergoing 
mitosis 
Total 
number of 
(tracked) 
cells 
Mean ratio    
+/- SEM  
Unpaired 
t-test 
 P value 
tnnt2aMO #1 0 30 0,104            
+/- 0,104 * 
P=0,034 
tnnt2aMO #2 5 24 
ccm2;tnnt2aMO #1 30 33 0,821             
+/- 0,087 ccm2;tnnt2aMO #2 33 45 
 
Video angiography during neurosurgical procedures. 25 mg of indocyanine green 
(ICG) was injected intravenously before surgical removal. The surgical situs was 
illuminated by a near-infrared laser excitation light source (lambda = 780 nm). The 
intravascular fluorescence of ICG (maximal lambda = 835 nm) was then recorded by a 
non-intensified video camera, with optical filtering to block ambient and laser light for 
collection of only ICG-induced fluorescence (Raabe et al., 2003). 
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